ArticleBlood advances2021

Long-term outcome of hyper-CVAD-R for Burkitt leukemia/lymphoma and high-grade B-cell lymphoma: focus on CNS relapse.

Bachar Samra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.